Optipharm.CO.,LTD (KOSDAQ: 153710)
South Korea
· Delayed Price · Currency is KRW 5,340.00
-40.00 (-0.74%)
Oct 11, 2024, 9:00 AM KST
Optipharm.CO.,LTD Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 18,560 | 17,373 | 16,008 | 14,258 | 13,046 | 13,653 | Upgrade
|
| Other Revenue | -0 | - | - | -0 | -0 | - | Upgrade
|
| Revenue | 18,560 | 17,373 | 16,008 | 14,258 | 13,046 | 13,653 | Upgrade
|
| Revenue Growth (YoY) | 12.02% | 8.52% | 12.27% | 9.29% | -4.45% | -2.19% | Upgrade
|
| Cost of Revenue | 14,173 | 13,177 | 12,293 | 10,522 | 9,539 | 9,157 | Upgrade
|
| Gross Profit | 4,387 | 4,195 | 3,715 | 3,736 | 3,507 | 4,496 | Upgrade
|
| Selling, General & Admin | 3,496 | 3,301 | 2,546 | 2,729 | 2,818 | 2,975 | Upgrade
|
| Research & Development | 2,877 | 2,946 | 2,632 | 5,022 | 3,670 | 2,168 | Upgrade
|
| Other Operating Expenses | 171.4 | 184.01 | 363.43 | 118.5 | 119.01 | 104.94 | Upgrade
|
| Operating Expenses | 6,951 | 6,826 | 5,904 | 8,241 | 6,961 | 5,687 | Upgrade
|
| Operating Income | -2,564 | -2,631 | -2,188 | -4,505 | -3,454 | -1,191 | Upgrade
|
| Interest Expense | -524.13 | -477.34 | -353.51 | -173.78 | -108.33 | -158.58 | Upgrade
|
| Interest & Investment Income | 624.96 | 665.39 | 464.38 | 234.2 | 325.36 | 501.51 | Upgrade
|
| Earnings From Equity Investments | -1.25 | -1.49 | -0.35 | -0.29 | -10.44 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.28 | 0.12 | -1.38 | -3.48 | -0.54 | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.84 | 6.52 | 31.2 | 1,370 | 881.6 | 198.31 | Upgrade
|
| EBT Excluding Unusual Items | -2,454 | -2,438 | -2,048 | -3,078 | -2,366 | -649.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.57 | 1.06 | 3.31 | -1.76 | 13.6 | -5.47 | Upgrade
|
| Pretax Income | -2,453 | -2,437 | -2,045 | -3,080 | -2,352 | -655.33 | Upgrade
|
| Net Income | -2,453 | -2,437 | -2,045 | -3,080 | -2,352 | -655.33 | Upgrade
|
| Net Income to Common | -2,453 | -2,437 | -2,045 | -3,080 | -2,352 | -655.33 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 0.29% | 0.45% | 0.54% | 0.66% | 1.30% | 15.49% | Upgrade
|
| EPS (Basic) | -167.23 | -166.10 | -140.00 | -212.00 | -163.00 | -46.00 | Upgrade
|
| EPS (Diluted) | -167.23 | -166.10 | -140.00 | -212.00 | -163.00 | -46.00 | Upgrade
|
| Free Cash Flow | -1,317 | -3,395 | -6,968 | -2,695 | -2,507 | -178.99 | Upgrade
|
| Free Cash Flow Per Share | -89.77 | -231.40 | -477.09 | -185.50 | -173.74 | -12.56 | Upgrade
|
| Gross Margin | 23.64% | 24.15% | 23.21% | 26.20% | 26.88% | 32.93% | Upgrade
|
| Operating Margin | -13.82% | -15.14% | -13.67% | -31.59% | -26.47% | -8.72% | Upgrade
|
| Profit Margin | -13.22% | -14.03% | -12.77% | -21.60% | -18.03% | -4.80% | Upgrade
|
| Free Cash Flow Margin | -7.09% | -19.54% | -43.53% | -18.90% | -19.22% | -1.31% | Upgrade
|
| EBITDA | -1,031 | -1,198 | -1,068 | -3,429 | -2,469 | -334.34 | Upgrade
|
| EBITDA Margin | -5.55% | -6.89% | -6.67% | -24.05% | -18.93% | -2.45% | Upgrade
|
| D&A For EBITDA | 1,534 | 1,433 | 1,120 | 1,076 | 984.42 | 856.68 | Upgrade
|
| EBIT | -2,564 | -2,631 | -2,188 | -4,505 | -3,454 | -1,191 | Upgrade
|
| EBIT Margin | -13.82% | -15.14% | -13.67% | -31.59% | -26.47% | -8.72% | Upgrade
|
| Advertising Expenses | - | 28.73 | 92.55 | 22.55 | 34.89 | 8.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.